Profiling response to TNF-inhibitor treatment in axial spondyloarthritis
Arthritis Care & Research Nov 17, 2017
Alazmi M, et al. - This inquiry was set up to assess the factors associated with TNF inhibitory (TNFi) failure types and their characteristics in axial spondyloarthritis (AxSpA). Nearly 40% of the TNFi failures in AxSpA patients were attributed to primary lack of response, which was independently predicted by older age, negative HLA-B27, higher baseline disease activity and treatment with sTNFR.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries